Novo Nordisk has told the world it expects patients to lose “at least 25%” of their body weight on its experimental drug ...
Eli Lilly strikes Zepbound deal with the telehealth platform Ro, amid questions about future of compounded GLP-1s.
Although the GLP-1 drug Zepbound has been shown to be effective in promoting weight loss, availability and price have been ...
Shares of Eli Lilly climbed early Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss ...
Nestle just rolled out a new protein shot drink that it says will help people looking to lose weight manage their hunger and ...
Eli Lilly just gave investors several reasons to cheer.
The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback